DRUG

Fe-TMPyP

3 hypotheses across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for Fe-TMPyP

ALS 3

Mediator Outcome Score Tier Lit. status Trial
α-synuclein Parkinson's disease 0.220 Mid novel signal none
α-synuclein neurodegenerative diseases 0.220 Mid novel signal none
α-synuclein multiple system atrophy 0.220 Mid novel signal none

Clinical trials

0 registered trials for Fe-TMPyP

Source: ClinicalTrials.gov

No registered trials found on ClinicalTrials.gov. This could indicate either an unexplored indication or a gap in registry coverage.

Search ClinicalTrials.gov →